select a format

Single User License
USD 2500 INR 160925
Site License
USD 5000 INR 321850
Corporate User License
USD 7500 INR 482775

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015


  • Products Id :- GDHC2582CTIDB
  • |
  • Pages: 80
  • |
  • February 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Anaplastic Thyroid Cancer Global Clinical Trials Review, H1, 2015" provides data on the Anaplastic Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Anaplastic Thyroid Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Anaplastic Thyroid Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons To Buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Anaplastic Thyroid Cancer 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Anaplastic Thyroid Cancer 25

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Anaplastic Thyroid Cancer Therapeutics Clinical Trials 31

Prominent Drugs 32

Clinical Trial Profiles 33

Clinical Trial Overview of Top Companies 33

OXiGENE, Inc. 33

Clinical Trial Overview of OXiGENE, Inc. 33

Bayer AG 34

Clinical Trial Overview of Bayer AG 34

Eisai Co., Ltd. 35

Clinical Trial Overview of Eisai Co., Ltd. 35

Daiichi Sankyo Company, Limited 36

Clinical Trial Overview of Daiichi Sankyo Company, Limited 36

GlaxoSmithKline plc 37

Clinical Trial Overview of GlaxoSmithKline plc 37

Genelux Corporation 38

Clinical Trial Overview of Genelux Corporation 38

Clinical Trial Overview of Top Institutes / Government 39

National Cancer Institute 39

Clinical Trial Overview of National Cancer Institute 39

Case Comprehensive Cancer Center 40

Clinical Trial Overview of Case Comprehensive Cancer Center 40

Memorial Sloan Kettering Cancer Center 41

Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 41

Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42

Clinical Trial Overview of Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino 42

University of Schleswig-Holstein 43

Clinical Trial Overview of University of Schleswig-Holstein 43

University of Colorado 44

Clinical Trial Overview of University of Colorado 44

University of Michigan Comprehensive Cancer Center 45

Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 45

University of Kentucky 46

Clinical Trial Overview of University of Kentucky 46

Leiden University Medical Center 47

Clinical Trial Overview of Leiden University Medical Center 47

Five Key Clinical Profiles 48

Appendix 77

Abbreviations 77

Definitions 77

Research Methodology 78

Secondary Research 78

About GlobalData 79

Contact Us 79

Disclaimer 79

Source 80

List of Figures

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

GlobalData Methodology 78

List of Tables

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 7

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 15

Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Anaplastic Thyroid Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Anaplastic Thyroid Cancer to Oncology Clinical Trials, E7 Countries (%), 2015* 18

Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Anaplastic Thyroid Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Anaplastic Thyroid Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Anaplastic Thyroid Cancer Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Anaplastic Thyroid Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Anaplastic Thyroid Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28

Anaplastic Thyroid Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31

Anaplastic Thyroid Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by OXiGENE, Inc., 2015* 33

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 34

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 35

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 36

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genelux Corporation, 2015* 38

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 39

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2015* 40

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 41

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero Universitaria molinette San Giovanni Battista di Torino, 2015* 42

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2015* 43

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 44

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2015* 45

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015* 46

Anaplastic Thyroid Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015* 47

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Anaplastic Thyroid Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Anaplastic Thyroid Cancer, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com